Pay to Marwadi

Company Profile

NEULAND LABORATORIES LTD.

NSE : NEULANDLABBSE : 524558ISIN CODE : INE794A01010Industry : Pharmaceuticals & DrugsHouse : Private
BSE7187.95204.1 (+2.92 % )
PREV CLOSE (Rs.) 6983.85
OPEN PRICE (Rs.) 6995.50
BID PRICE (QTY) 7171.20 (8 )
OFFER PRICE (QTY) 7187.80 (2 )
VOLUME 2761
TODAY'S LOW / HIGH (Rs.)6918.65 7269.40
52 WK LOW / HIGH (Rs.)2006 7794
NSE7205.85 232.45 (+3.33 % )
PREV CLOSE(Rs.) 6973.40
OPEN PRICE (Rs.) 6973.40
BID PRICE (QTY) 7200.00 (16 )
OFFER PRICE (QTY) 7205.85 (2 )
VOLUME 17408
TODAY'S LOW / HIGH(Rs.) 6940.00 7274.15
52 WK LOW / HIGH (Rs.)2009.05 7790

Quaterly Results

(Rs in Million)
";
Particulars Dec 2023 Sep 2023 Jun 2023 Mar 2023
Audited / UnAudited UnAudited UnAudited UnAudited Audited
Net Sales 3928.28 4177.49 3629.94 4070.73
Total Expenditure 2715.63 2802.61 2660.73 2872.14
PBIDT (Excl OI) 1212.65 1374.88 969.21 1198.59
Other Income 21.01 30.48 20.39 80.64
Operating Profit 1233.66 1405.35 989.6 1279.23
Interest 37.41 44.33 22.14 42.89
Exceptional Items NA NA NA NA
PBDT 1196.25 1361.02 967.46 1236.34
Depreciation 151.44 145.08 135.86 134.7
Profit Before Tax 1044.81 1215.94 831.6 1101.64
Tax 230.91 323.46 212.81 256.2
Provisions and contingencies NA NA NA NA
Profit After Tax 813.9 892.48 618.79 845.43
Extraordinary Items NA NA NA NA
Prior Period Expenses NA NA NA NA
Other Adjustments NA NA NA NA
Net Profit 813.9 892.48 618.79 845.43
Minority Interest NA NA NA NA
Shares of Associates
Other related items
Misc. Expenses Written off NA NA NA NA
Consolidated Net Profit 813.9 892.48 618.79 845.44
Equity Capital 129 129.01 129.01 129.01
Face Value (IN RS) 10 10 10 10
Reserves NA NA NA NA
Calculated EPS 63.09 69.17 47.96 65.53
Calculated EPS (Annualised) 252.37 276.71 191.85 262.13
No of Public Share Holdings 8621410 8214946 8206857 8192857
% of Public Share Holdings 67.2 64.03 63.97 63.86
  NA NA NA NA
PBIDTM% (Excl OI) 30.86 32.91 26.70 29.44
PBIDTM% 31.40 33.64 27.26 31.42
PBDTM% 30.45 32.57 26.65 30.37
PBTM% 26.59 29.10 22.90 27.06
PATM% 20.71 21.36 17.04 20.76
 Notes Notes Notes Notes